濮阳东方看妇科技术可靠-【濮阳东方医院】,濮阳东方医院,濮阳东方医院割包皮手术口碑好不好,濮阳东方收费很低,濮阳东方医院男科评价很高,濮阳东方妇科医院具体位置在哪,濮阳东方医院看妇科收费非常低,濮阳东方医院看男科收费低
濮阳东方看妇科技术可靠濮阳东方医院男科技术可靠,濮阳东方医院男科看阳痿口碑很不错,濮阳东方医院治疗阳痿技术好,濮阳东方医院男科治阳痿很靠谱,濮阳东方看男科病口碑很好价格低,濮阳东方妇科医院做人流手术很不错,濮阳东方妇科好不好啊
BEIJING, Feb. 23 (Xinhua) -- A senior official of the ruling Forces pour la Defense de la Democratie (FDD) of Burundi said Tuesday the FDD hopes to strengthen cooperation with the Communist Party of China (CPC) and to further enhance the "brotherly friendship" with the CPC.Mohamed Rukara, vice president of the Council of Elders, the top decision-making body of the FDD, said in an interview with Xinhua that there are a lot of ruling experiences of CPC that the FDD can learn from.He said the CPC has gained great achievements in China's reform and opening up, realizing sustainable development, developing science and technology and striking corruption.He said Burundi has set "sustainable development" as the slogan for the 2010-2015 period, and he believed that his country can learn from China's successful experiences of reform and opening up and realize the goal of shaking off poverty by 2020-2025.Rukara, who is also a ombudsman, said corruption has been a big challenge facing his country, and he believed the FDD can learn from the CPC in this regard, as the latter has been combating corruption very hard and effectively.Appreciating China's aid and contribution to the development of Burundi, Rukara said the two parties and the two countries have had very good relations based on mutual respect.He welcomed more Chinese enterprises to invest in Burundi to support its development, and "the door will always be open to our brother."At the invitation of the CPC, Rukara is heading an FDD delegation for a visit to China starting from Saturday.
MOSCOW, May 13 (Xinhua) -- The main and backup crews that will fly to the International Space Station in June have passed preflight tests and are ready for space travel, the Russian Cosmonauts Training Center said Friday.The main crew includes Russian cosmonaut Sergei Volkov, Japanese astronaut Satoshi Furukawa and American astronaut Michael Fossuma.A Russian spaceship Soyuz TMA-02M will send the crew to the space station on June 8, Interfax news agency reported.The backup crew includes members from Russia, the Netherlands and the United States.The crews were tested on the various emergency situations they could face during the flight.Next Monday, the commission will make a final choice of crewmembers for the launch.The crew will spend 161 days in orbit and conduct three space walks.
BEIJING, March 8 (Xinhuanet) -- U.S. Food and Drug Administration (FDA) announced there was no new reason for safety concern in Pfizer Inc's Prevenar and Sanofi Aventis SA's ActHIBor vaccines, according to media reports Tuesday.Health agencies "have not detected new safety concerns or unusual reporting patterns" in the vaccines, which are used to prevent forms of meningitis and pneumonia, FDA spokeswoman Shelly Burgess said in an emailed statement.Health agencies in the United States will continue to monitor the vaccines for safety, the spokeswoman added.The Japanese health ministry had decided to suspend the vaccines after four unexplained deaths were reported. The causes of the deaths are still investigated, the Japanese ministry said in a release on its website.
WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.
LOS ANGELES, April 11 (Xinhua) -- Drinking 100-percent fruit juice may offer disease-fighting benefits, a new study suggests.Fruit juice is linked with reduced risk of cancer, improved markers of heart health and cognitive decline, and increased antioxidant activity, according to the study published on Monday by the American Association for the Advancement of Science (AAAS).These protective health benefits are similar to those of whole fruits, said the study, conducted by researchers at the University of California, Davis.The researchers came to the conclusion after summarizing recent research data on the potential benefits of fruit juice. The review included a range of study types, from in vitro to clinical trials (60 papers total), all published in 2005 or later.Among the fruit juices included in the review, consumption of apple, citrus, cranberry, grape, and pomegranate juices all showed beneficial effects. Markers of improved health ranged from reductions in urinary tract infections (cranberry) to improvements in age-related cognitive decline (grape and apple) to reduced risk of prostate (pomegranate) and respiratory and digestive (orange, grapefruit) cancers. Additionally, intake of all juices was linked to heightened antioxidant activity."While it is universally accepted that fruit and vegetable intake is protective, there is not a clear consensus about the benefits of consuming the juices that are extracted from them," said study lead author Dianne Hyson, PhD. "An analysis of the scientific evidence suggests that 100 percent fruit juices retain important bioactive components that may promote good health and aid in disease prevention."